Tue, October 3, 2023
Mon, October 2, 2023
Sun, October 1, 2023
Fri, September 29, 2023
Thu, September 28, 2023
Wed, September 27, 2023
Tue, September 26, 2023

Gary Nachman Initiated (ALNY) at Buy and Held Target at $208 on, Sep 29th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. buy-and-held-target-at-208-on-sep-29th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Gary Nachman of Raymond James, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $208 on, Sep 29th, 2023.

Gary has made no other calls on ALNY in the last 4 months.



There are 8 other peers that have a rating on ALNY. Out of the 8 peers that are also analyzing ALNY, 2 agree with Gary's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Olivia Brayer of "Cantor Fitzgerald" Reiterated at Hold and Held Target at $190 on, Thursday, September 14th, 2023
  • Michael Ulz of "Morgan Stanley" Reiterated at Hold and Held Target at $210 on, Friday, August 4th, 2023


These are the ratings of the 6 analyists that currently disagree with Gary


  • Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $405 on, Monday, September 18th, 2023
  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $240 on, Thursday, September 14th, 2023
  • Luca Issi of "RBC Capital" Reiterated at Buy and Held Target at $270 on, Tuesday, September 12th, 2023
  • Keay Nakae of "Chardan Capital" Reiterated at Strong Buy and Held Target at $250 on, Tuesday, August 8th, 2023
  • David Lebovitz of "Citigroup" Maintained at Strong Buy with Increased Target to $266 on, Friday, August 4th, 2023

Publication Contributing Sources